Metabolic/CardiovascularOtherPositive observation
Record detail Table 4 entry 1: Bradykinin ex-vivo stability t1/2 5.29 ± 0.5 min
- Measure
- other
- Value
- 5.29 ± 0.5 min (half_life)
- Target
- Mus musculus
- Assay
- Not reported by source
Primary literature evidence
Experimental evidence search
Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.
Evidence records
4 results
Metabolic/CardiovascularOtherPositive observation
Record detail Figure 4b: Bradykinin injection induced a decrease in MAP (~Δ 23 mmHg)
- Measure
- other
- Value
- ~Δ 23 mmHg
- Target
- Rattus norvegicus
- Assay
- Not reported by source
Metabolic/CardiovascularOtherPositive observation
Record detail Figure 5a: Bradykinin B2R binding IC50 low nM range
- Measure
- other
- Value
- low nM range
- Target
- B2R
- Assay
- Not reported by source
ImmunomodulatoryOtherPositive observation
Record detail Figure 5a: Bradykinin EC50 for PGE2 release in nanomolar range
- Measure
- EC50
- Value
- nanomolar range
- Target
- 3T3
- Assay
- Not reported by source
Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.